Veracyte, Inc.
VCYT
$58.89
$2.133.75%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 28.71M | 41.15M | 19.14M | -980.00K | 7.05M |
| Total Depreciation and Amortization | 5.43M | 5.30M | 5.27M | 5.49M | 5.36M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.81M | 658.00K | 13.97M | 27.87M | 7.46M |
| Change in Net Operating Assets | -11.73M | 5.48M | 6.38M | 1.23M | -14.50M |
| Cash from Operations | 35.22M | 52.58M | 44.76M | 33.61M | 5.36M |
| Capital Expenditure | -2.96M | -3.78M | -2.79M | -1.29M | -1.82M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -2.85M | -- | -- | -- |
| Other Investing Activities | -125.00M | 1.20M | 51.06M | 1.06M | -50.00M |
| Cash from Investing | -127.96M | -5.43M | 48.26M | -224.00K | -51.82M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.74M | 3.51M | 5.79M | 1.81M | 2.97M |
| Repurchase of Common Stock | -9.36M | -3.66M | -2.81M | -2.38M | -9.45M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -6.63M | -149.00K | 2.98M | -566.00K | -6.48M |
| Foreign Exchange rate Adjustments | -58.00K | 12.00K | 60.00K | 573.00K | 74.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -99.43M | 47.02M | 96.06M | 33.39M | -52.87M |